[1] PLUTA R M,LYNM C,GLASS R M.JAMA patient page.Pertussis[J].JAMA,2010,304(8):922.
[2] YEUNG K H T,DUCLOS P,NELSON E A S,et al.An update of the global burden of pertussis in children younger than 5 years:a modelling study[J].Lancet Infect Dis,2017,17(9):974-980.
[3] Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet (London,England),2020,396(10258):1204-1222.
[4] 张倩,吴丹,郑徽,等.中国2022年百日咳流行病学特征[J].中国疫苗和免疫,2024,30(1):34-38.
[5] ZHANG Z,PAN J,CHEN M,et al.Seroepidemiology of pertussis in China:a population-based,cross-sectional study[J].Vaccine,2021,39(12):1687-1692.
[6] 董琴琴,吴维仪,梁明欣,等.儿童百日咳的诊治进展[J].现代临床医学,2024,50(3):219-222.
[7] 张艳炜,梁静,卢紫燕,等.不同免疫状态和年龄对百日咳患儿临床表现的影响[J].中华传染病杂志,2020,38(7):440-443.
[8] CARVALHO C F A,ANDREWS N,DABRERA G,et al.National outbreak of pertussis in England,2011-2012:a case-control study comparing 3-component and 5-component acellular vaccines with whole-cell pertussis vaccines[J].Clin Infect Dis,2020,70(2)200-207.
[9] DALBY T,ANDERSEN P H,HOFFMANN S.Epidemiology of pertussis in Denmark,1995 to 2013[J].Eurosurveillance,2016,21(36):30334.
[10] NING G,GAO Y,WU D,et al.Epidemiology of pertussis in China,2011-2017[J].Chin J Vaccines Immun,2018,24(3):264-267.
[11] SKOFF T H,HADLER S,HARIRI S.The epidemiology of nationally reported pertussis in the United States,2000-2016[J].Clin Infec Dis,2019,68(10):1634-1640.
[12] ZHANG Q,HAN F,NIE Q,et al.Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China[J].J Infection,2011,63(6):441-446.
[13] 康小娟,彭晓康,李亚绒,等.儿童百日咳痉挛性咳嗽演变与白细胞和淋巴细胞水平的关系[J].中国妇幼健康研究,2023,34(8):63-69.
[14] 罗晶晶,黎耀文,田晓旭,等.283例儿童百日咳住院病例临床特征及重症百日咳相关危险因素分析[J].新发传染病电子杂志,2024,9(3):5-10.
[15] 张继燕,卓裕霏,陈艳萍,等.儿童百日咳住院病例248例临床特征及重症百日咳相关危险因素分析[J].中华实用儿科临床杂志,2023,38(4):275-280.
[16] VANDERENDE K,GACIC-DOBO M,DIALLO M S,et al.Global routine vaccination coverage-2017[J]. MMWR Morb Mortal Wkly Rep,2018,67(45):1261-1264.
[17] YU J,HE H,ZHANG Y,et al.Burden of whooping cough in China (Pertussis China):study protocol of a prospective,population-based case-control study[J].BMJ Open,2022,12(3):e053316.
[18] KANG L,CUI X,FU J,et al.Clinical characteristics of 967 children with pertussis:a single-center analysis over an 8-year period in Beijing,China[J].Eur J Clin Microbiol,2022,41(1):9-20.
[19] BECHINI A,TISCIONE E,BOCCALINI S,et al.Acellular pertussis vaccine use in risk groups (adolescents,pregnant women,newborns and health care workers):a review of evidences and recommendations[J].Vaccine,2012,30(35):5179-5190.
[20] BIRRU F,AL-HINAI Z,AWLAD THANI S,et al.Critical pertussis:a multi-centric analysis of risk factors and outcomes in Oman[J].IJID,2021,107:53-58.
[21] 宋春燕,关宇凤.血小板计数水平与肺炎患儿病情严重程度的关系[J].泰山医学院学报,2017(9):2.
[22] 王婧文,王学莲,底建辉.儿童社区获得性肺炎血清MLR、PLR与疾病严重程度的相关性及危险因素分析[J].中国实验诊断学,2023,27(10):1170-1174.
[23] 张林.婴幼儿呼吸道合胞病毒毛细支气管炎复发喘息相关危险因素分析及趋化因子表达的临床意义探讨[D].苏州:苏州大学,2023.
[24] 樊华峰,陈媛,徐鹏飞,等.中性粒细胞与淋巴细胞比值在儿童流感重症化中的价值[J].检验医学与临床,2022,19(13):1824-1827.
[25] 于芹.儿童流行性感冒相关死亡病例临床特点及危险因素分析[D].沈阳:中国医科大学,2021.
[26] 朱小健,万浩,余倩.白细胞衍生性指标在儿童肺炎严重程度及预后评估中的应用观察[J].实用医技杂志,2024,31(5):360-365.
[27] 赵艳,汤磊,尹丽娟,等.基于临床特征的儿童重症百日咳早期预警危险因素Meta分析[J].中国疫苗和免疫,2020,26(4):460-467.
[28] 雷伟,李发富.胱抑素C儿童急性肾损伤病情评估与价值分析[J].国际检验医学杂志,2015,36(14):2002-2004.
[29] 陈正徐,王秀丽,饶晓红,等.血、尿胱抑素C检测对小儿肺炎肾功能监测的临床研究[J].实验与检验医学,2012,30(3):236-238. |